Rocket Pharmaceuticals Shares Rise After Goldman Sachs Upgrade

MT newswire2026/10/08 19:11

03:11 PM EDT, 10/08/2026 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) shares were up over 4% in Thursday trading after Goldman Sachs upgraded the stock to neutral from sell, with a price target of $4. Trading volume stood at more than 2.1 million shares, compared with a daily average of about 1.7 million. Price: 2.64, Change: +0.11, Percent Change: +4.14

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq

Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

智通财经•2026/11/09 06:12

UniCredit: Third-quarter net profit reaches 3.26 billion euros, exceeding expectations

格隆汇•2026/11/09 06:11

UK funds significantly reduced their holdings in SpaceX last week and had fully exited Tesla as of April.

格隆汇•2026/11/09 05:55

Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF

FXStreet•2026/11/09 05:45